Some scientists believe that DMT could revolutionize the treatment of depression.
Alzheimer's has proved difficult to treat. But solving the mystery of this ultra-rare frontotemporal dementia may unlock new understanding.
Theoretical physicist Geoffrey West explains the science behind a unique hypothesis.
Antisense oligonucleotide therapy uses small molecules to alter RNA. Researchers have now used those molecules to alleviate a genetic form of blindness.
A team of biohackers is on a David-versus-Goliath mission to make insulin affordable to an increasing number of diabetics.
How were mRNA vaccines developed? Pfizer's Dr Bill Gruber explains the science behind this record-breaking achievement and how it was developed without compromising safety.
She helped create CRISPR, a gene-editing technology that is changing the way we treat genetic diseases and even how we produce food.
An early feasibility study finds a potential new treatment for Alzheimer's disease.
Vaccines can be grown in and extracted from the leaves of plants.
Engineered immune cells have prevented Type 1 diabetes in mice.
Many thousands of different genetic variants are responsible for complex behavior.
The tiny swimmers appear to transmit signals that "persuade" the female body to have a baby.
"The question is which are okay, which are not okay."
A new study finds an unusual genetic difference in people over 105.
New machine-learning algorithms from Columbia University detect cognitive impairment in older drivers.
Healthy people need healthy microbiomes from an early age.